202 related articles for article (PubMed ID: 17465230)
1. Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis.
Vairaktaris E; Yapijakis C; Psyrri A; Spyridonidou S; Yannopoulos A; Lazaris A; Vassiliou S; Ferekidis E; Vylliotis A; Nkenke E; Patsouris E
Anticancer Res; 2007; 27(2):979-84. PubMed ID: 17465230
[TBL] [Abstract][Full Text] [Related]
2. Cell proliferation and apoptosis culminate in early stages of oral oncogenesis.
Derka S; Vairaktaris E; Papakosta V; Vassiliou S; Acil Y; Vylliotis A; Spyridonidou S; Lazaris AC; Mourouzis C; Kokkori A; Moulavasili P; Perrea D; Donta I; Yapijakis C; Patsouris E
Oral Oncol; 2006 May; 42(5):540-50. PubMed ID: 16464633
[TBL] [Abstract][Full Text] [Related]
3. The hamster model of sequential oral oncogenesis.
Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
[TBL] [Abstract][Full Text] [Related]
4. Abundance and localization of skeletal muscle-related erbB2 may stimulate tumour growth during initial stages of oral oncogenesis.
Vairaktaris E; Moulavassili P; Loukeri S; Spyridonidou S; Yapijakis C; Vassiliou S; Nkenke E; Vylliotis A; Papakosta V; Lazaris A; Patsouris E
J Musculoskelet Neuronal Interact; 2007; 7(2):185-90. PubMed ID: 17627089
[TBL] [Abstract][Full Text] [Related]
5. H-ras and c-fos exhibit similar expression patterns during most stages of oral oncogenesis.
Vairaktaris E; Papakosta V; Derka S; Vassiliou S; Nkenke E; Spyridonidou S; Vylliotis A; Lazaris A; Kokkori A; Moulavassili P; Loukeri S; Perrea D; Donta I; Yapijakis C; Patsouris E
In Vivo; 2008; 22(5):621-8. PubMed ID: 18853758
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell cycle regulator p16 is not affected by diabetes during oral oncogenesis.
Vairaktaris E; Goutzanis L; Nkenke E; Spyridonidou S; Vassiliou S; Derka S; Vylliotis A; Yapijakis C; Lazaris A; Patsouris E
In Vivo; 2007; 21(5):745-50. PubMed ID: 18019407
[TBL] [Abstract][Full Text] [Related]
7. The co-expression of c-myc and p53 increases and reaches a plateau early in oral oncogenesis.
Papakosta V; Vairaktaris E; Vylliotis A; Derka S; Nkenke E; Vassiliou S; Lazaris A; Mourouzis C; Rallis G; Spyridonidou S; Anagnostopoulou S; Perrea D; Donta I; Yapijakis C; Patsouris E
Anticancer Res; 2006; 26(4B):2957-62. PubMed ID: 16886620
[TBL] [Abstract][Full Text] [Related]
8. Expression of survivin and XIAP for DMBA-induced hamster buccal pouch squamous cell carcinogenesis is associated with p53 accumulation.
Hsue SS; Chen YK; Lin LM
Oral Oncol; 2008 Jan; 44(1):43-9. PubMed ID: 17306609
[TBL] [Abstract][Full Text] [Related]
9. Effects of thalidomide on DMBA-induced oral carcinogenesis in hamster with respect to angiogenesis.
Yang Y; Ge JP; Zhou ZT
J Oral Pathol Med; 2009 May; 38(5):455-62. PubMed ID: 19141066
[TBL] [Abstract][Full Text] [Related]
10. EGFR and c-Jun exhibit the same pattern of expression and increase gradually during the progress of oral oncogenesis.
Vairaktaris E; Loukeri S; Vassiliou S; Nkenke E; Spyridonidou S; Vylliotis A; Papakosta V; Lazaris A; Agrogiannis G; Yapijakis C; Perrea D; Patsouris E
In Vivo; 2007; 21(5):791-6. PubMed ID: 18019413
[TBL] [Abstract][Full Text] [Related]
11. [Synergism of c-myc and p16 in oral squamous cell carcinoma].
Liu NG; Shan CM; Wu SH; Lu ZH; Kang GY
Ai Zheng; 2004 Jun; 23(6):635-9. PubMed ID: 15191661
[TBL] [Abstract][Full Text] [Related]
12. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
Liu HW; Hu BQ; Cao CF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
[TBL] [Abstract][Full Text] [Related]
13. Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis.
Vairaktaris E; Kalokerinos G; Goutzanis L; Spyridonidou S; Vassiliou S; Derka S; Nkenke E; Yapijakis C; Vylliotis A; Lazaris A; Patsouris E
Anticancer Res; 2007; 27(3B):1465-73. PubMed ID: 17595763
[TBL] [Abstract][Full Text] [Related]
14. Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas.
Shahnavaz SA; Bradley G; Regezi JA; Thakker N; Gao L; Hogg D; Jordan RC
Cancer Res; 2001 Mar; 61(6):2371-5. PubMed ID: 11289098
[TBL] [Abstract][Full Text] [Related]
15. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
16. Diabetes and oral oncogenesis.
Vairaktaris E; Spyridonidou S; Goutzanis L; Vylliotis A; Lazaris A; Donta I; Perrea D; Yapijakis C; Patsouris E
Anticancer Res; 2007; 27(6B):4185-93. PubMed ID: 18225590
[TBL] [Abstract][Full Text] [Related]
17. Cloning of hamster osteopontin and expression distribution in normal tissues and experimentally induced oral squamous-cell carcinoma.
Jin H; Valverde P; Chen J
Arch Oral Biol; 2006 Mar; 51(3):236-45. PubMed ID: 16095557
[TBL] [Abstract][Full Text] [Related]
18. FGFR-2 and -3 play an important role in initial stages of oral oncogenesis.
Vairaktaris E; Ragos V; Yapijakis C; Derka S; Vassiliou S; Nkenke E; Yannopoulos A; Spyridonidou S; Vylliotis A; Papakosta V; Loukeri S; Lazaris A; Tesseromatis C; Tsigris C; Patsouris E
Anticancer Res; 2006; 26(6B):4217-21. PubMed ID: 17201136
[TBL] [Abstract][Full Text] [Related]
19. The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system.
Tokman B; Gultekin SE; Sezer C; Alpar R
Saudi Med J; 2004 Dec; 25(12):1922-30. PubMed ID: 15711668
[TBL] [Abstract][Full Text] [Related]
20. [The relationship between methylation of p16 INK 4/CDKN2 gene in promoter region and progress of squamous cell carcinoma of buccal mucosa].
Dong YY; Wang J; Dong FS; Wang X; Li HX; Gu HT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 May; 41(5):297-8. PubMed ID: 16784614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]